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Abstract  
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Background: Immune system dysfunction may be associated with eating disorders, and 
associations may have implications for detection, risk assessment, and treatment of both 
autoimmune diseases and eating disorders. However, the nature of the relationship between these 
two disease entities remains unclear. We evaluated the strength of associations for the 
bidirectional relationships between eating disorders and autoimmune diseases. Methods: In this 
nationwide population-based cohort study, Swedish registers were linked to establish a cohort of 
over two and a half million individuals born in Sweden between January 1, 1979 and December 
31, 2005 and followed-up until December 2013. Two Cox proportional hazard regression models 
were used to investigate 1) subsequent risk of eating disorders in individuals with autoimmune 
diseases and 2) subsequent risk of autoimmune diseases in individuals with eating disorders. 
Results: We observed a strong, bidirectional relationship between the two classes of illness 
indicating that diagnosis of one illness increased the risk of the other. In women, autoimmune 
disease exposure increased subsequent hazard of anorexia nervosa, bulimia nervosa, and other 
eating disorders. Likewise, anorexia nervosa, bulimia nervosa, and other eating disorders 
increased subsequent hazard of autoimmune diseases. The gastrointestinal-related autoimmune 
diseases celiac and Crohn's showed a bidirectional relationship with anorexia nervosa and other 
eating disorders. Psoriasis showed a bidirectional relationship only with other eating disorders. 
Prior type 1 diabetes increased risk for anorexia nervosa, bulimia nervosa, and other eating 
disorders. In men, we did not observe a bidirectional pattern, but prior autoimmune arthritis 
increased risk for other eating disorders. Conclusions: The associations between eating disorders 
and autoimmune diseases provide support for previously reported associations and the 
bidirectional risk pattern observed suggests either a shared underlying mechanism or a third 
explanatory variable contributing to the association of these illnesses. 
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Introduction 
Autoimmunity has been implicated in several psychiatric disorders (Barbuti et al., 2017; 
Eaton et al., 2006; Edmiston, Ashwood, & Van de Water, 2017; Frick & Pittenger, 2016; 
Mechawar & Savitz, 2016; Muskens, Velders, & Staal, 2017; Neigh & Ali, 2016; Tylee et al., 
2017; Volk, 2017; see eTable 1 for a review), including eating disorders (Raevuori et al., 2014; 
Wotton, James, & Goldacre, 2016; Zerwas et al., 2017). Moreover, the first genome-wide 
significant association in anorexia nervosa (AN) was identified (Duncan et al., 2017) in a region 
previously implicated in autoimmune diseases, including type 1 diabetes (Barrett et al., 2009) 
and arthritis (Okada et al., 2014).  
 Eating disorders and autoimmunity are complex traits influenced by numerous genetic 
variants acting additively in combination with environmental factors to influence phenotypic 
expression (Yilmaz, Hardaway, & Bulik, 2015). Autoimmunity varies on a continuum, ranging 
from no clinical consequences to pathogenic autoimmunity causing inflammatory organ 
infiltration, tissue damage, and overt disease-specific symptomatology. Autoimmune diseases 
occur in ~7-9% of the population and increase with age (Theofilopoulos, Kono, & Baccala, 
2017). 
Extensive Swedish health registers afforded an exploration of bidirectional associations 
between eating disorders and autoimmune diseases (eTable 2). We extended prior studies 
(Raevuori et al., 2014; Wotton et al., 2016; Zerwas et al., 2017) by examining a cohort of more 
than 2.5 million individuals. 
 
 
 
Methods 
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Study Population and Data Sources  
We studied individuals aged 0-35 years born in Sweden between January 1, 1979 and 
December 31, 2005, excluding those who emigrated or died before age 8, or were from 
multiparous births, to reduce nesting. Individuals were followed until eating disorder onset, 
autoimmune disease onset, death, emigration from Sweden, or the end of the follow-up period 
(December 31, 2013), whichever came first. We linked registers using the national personal 
identification number (Ludvigsson, Otterblad-Olausson, Pettersson, & Ekbom, 2009). Consistent 
with prior research (Mårild et al., 2017; Mustelin et al., 2017; Yao et al., 2016), birth year and 
sex were from the Total Population Register (Ludvigsson et al., 2016); migration data were from 
the Migration Register (Statistics Sweden); causes of death were from the Cause of Death 
Register (Statistics Sweden); and socioeconomic status (SES) was estimated using highest 
parental education (i.e., completed year 9 or below; completed year 12; >2 years tertiary) from 
the Longitudinal Integration Database for Health Insurance and Labour Market Studies (Statistics 
Sweden, 2012) when the child was 8 years old. The study was approved by the Regional Ethical 
Review Board in Stockholm, Sweden. 
Eating Disorder Outcomes 
Eating disorder diagnoses were from the National Patient Register (NPR), which tracks 
all inpatient care since 1987 and outpatient care since 2001 (Ludvigsson et al., 2011; Center for 
Epidemiology at the National Board of Health and Welfare, n.d.); Riksät-National Quality 
Register for Treatment for Eating Disorders (since 1999) (Emilsson, Lindahl, Köster, Lambe, & 
Ludvigsson, 2015); the regional quality assurance system for eating disorders, Stepwise (since 
2005; Birgegård, Björck, & Clinton, 2010); and the clinical database for child and adolescent 
psychiatry in Stockholm, Pastill (since 2001; Lindevall, 2009). NPR discharge diagnoses were 
from Swedish ICD-9 and ICD-10 (Smedby, 2006). In Riksät and Stepwise, eating disorder 
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diagnoses were based on DSM-IV-TR (American Psychiatric Association, 2005) (Birgegård et 
al., 2010). Coverage in Riksät and Stepwise has increased over time (Javaras et al., 2015). Pastill 
eating disorder diagnoses were based on ICD-10 or DSM-IV from Child and Adolescent Mental 
Health Services in Stockholm County (Lindevall, 2009). 
 Four eating disorder outcomes were evaluated: 1) AN: 307B (Swedish ICD-9); F50.0 or 
F50.1 (ICD-10); or DSM-IV AN or atypical AN; 2) Other eating disorders: 307F (Swedish ICD-
9); F50.2, F50.3, or F50.9 (ICD-10); or DSM-IV bulimia nervosa (BN), atypical BN, binge-
eating disorder (BED), or eating disorder not otherwise specified (EDNOS). 3) Any eating 
disorder: included all individuals with an AN, BN, and/or other eating disorder diagnosis. 
Consistent with previous reports (Allen, Byrne, Oddy, & Crosby, 2013; Stice, Marti, & Rohde, 
2013), many individuals had both AN and other eating disorders (at different times) and are 
included as incident cases for both the AN and other eating disorder outcomes. Thus, the number 
of incident cases of AN and/or other eating disorders is greater than the number of incident cases 
of any eating disorder, where each individual can be an incident case only once. Analysis of any 
eating disorder provide information on the overall incidence of eating disorders without inflation 
due to diagnostic crossover. 4) BN: included all individuals who received a BN diagnosis in the 
NPR (F50.2, F50.3) since 1997 or in Riksät, Stepwise, or Pastill. Analyses of BN are considered 
secondary because the years of observation are fewer than for the other diagnostic groups. BED 
and EDNOS could not be separated because Swedish ICD-9 only included a heterogeneous 
category (eating disorders other than AN) and F50.8, from ICD-10, was not consistently used to 
code BED prior to DSM-5. 
Age of onset reflects first contact with the respective diagnosis in the NPR, Riksät, 
Stepwise, or Pastill after the 8th birthday. The minimum age of onset for eating disorders was 8 to 
avoid diagnostic misclassification (e.g., childhood feeding difficulties; N excluded=4,493).  
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Autoimmune Disease Outcome  
Autoimmune disease diagnoses were obtained from the NPR using Swedish ICD 
revisions 8-10 diagnoses based on year of diagnosis. We evaluated any autoimmune disease as a 
group, and by specific categories: celiac disease, Crohn's disease, ulcerative colitis, psoriasis, 
arthritis, lupus, and type 1 diabetes (eTable 2). Age of onset was age at first contact with the 
respective diagnosis in the NPR with no minimum age of onset.  
Statistical Analyses 
Data management was conducted with SAS version 9.4; analyses were conducted with 
STATA version 14. False discovery rate (FDR) corrections were made for each predefined set of 
hypothesis tests (n=128) (Benjamini & Hochberg, 2000; Glickman, Rao, & Schultz, 2014). 
To optimize our longitudinal data, we performed two sets of Cox proportional hazard 
regression models estimating the relative hazards of eating disorders following autoimmune 
disease exposure and autoimmune disease risk following eating disorder exposure. In the first 
set, autoimmune disease status (presence/absence) was treated as time-dependent exposure and 
calendar year (1987-1996, 1997-2006, 2007-2013) was adjusted for as a time varying variable; 
all other variables were considered time-independent. For each analysis, we estimated hazard 
ratios (HR) for eating disorders in individuals exposed to an autoimmune disease compared to 
those not exposed. In the second set of analyses, we estimated HRs for autoimmune diseases, 
comparing individuals exposed to an eating disorder to those not exposed, with eating disorder 
status as a time-varying exposure variable. All estimates were adjusted for calendar-time in the 
parametric part of the Cox model, and for age in the nonparametric part. SES was entered as a 
covariate into all models. In Cox models, HRs greater than 1 indicate a higher risk of illness, 
whereas HRs less than 1 indicate a lower risk of illness compared with unaffected individuals. 
Analyses were applied to males and females separately.  
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Significantly increased HRs, after FDR correction, for an autoimmune disease after 
eating disorder exposure were investigated for effects of temporal proximity by calculating HR 
for ≤1 year, >1 year to ≤4 years, and >4 years between exposure and outcome. Due to possible 
misdiagnosis of eating disorders before age 8, we did not explore temporal proximity between 
autoimmune disease exposure and eating disorder onset. Furthermore, we did not investigate 
different ages of eating disorder onset as age of onset distributions revealed no evidence of bi- or 
multimodal patterns justifying such an approach, rendering any age at onset cutoff arbitrary 
(Figures 1a and 1b). 
 
 
Results  
Our cohort comprised 2,545,611 individuals (51.4% males, 48.6% females) followed 
over 33,640,644 person-years (range: 1 month to 22 years).  
Sample characteristics 
Table 1 presents prevalence and age at first diagnosis. Eating disorders occurred more 
commonly in females (2.0%) than in males (0.1%): 94% of eating disorder cases were female. 
 The most common autoimmune diseases were celiac disease, type 1 diabetes, and 
psoriasis. A higher percentage of females than males were diagnosed with an autoimmune 
disease.   
Risk of Eating Disorders Following Exposure to Autoimmune Disease  
Tables 2a and 2b provide the results from the Cox regression models estimating HRs of 
eating disorders after an autoimmune disease exposure in males and females, respectively. The 
following sections only present significant results. 
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In males, any preceding autoimmune disease was associated with an 82% increased 
hazard in other eating disorders, a 78% increased hazard in any eating disorder, and a 56% 
increased hazard for BN. In females, any preceding autoimmune disease increased the hazard for 
AN by 59%, for other eating disorders by 71%, for any eating disorder by 62%, and for BN by 
57%. 
We also evaluated the risk for subsequent eating disorders following exposure to celiac 
disease, Crohn's disease, ulcerative colitis, psoriasis, arthritis, lupus, and type 1 diabetes. In 
males, exposure to arthritis increased the risk for other eating disorders by 357% and any eating 
disorder by 267%, however, the assumption of proportional hazards was violated. In females, the 
risk for subsequent AN was increased after celiac disease (50%), Crohn’s disease (89%), and 
type 1 diabetes (71%). Moreover, celiac disease (47%), Crohn’s disease (63%), ulcerative colitis 
(52%), psoriasis (33%), and type 1 diabetes (153%) increased risk for subsequent other eating 
disorders. Risk for any eating disorder was increased after exposure to celiac disease (45%), 
Crohn’s disease (61%), ulcerative colitis (49%), psoriasis (27%), and type 1 diabetes (119%). 
Risk for subsequent BN was increased by 222% by an earlier diagnosis of type 1 diabetes.  
Risk of Autoimmune Disease Following Exposure to an Eating Disorder 
Tables 3a and 3b provide the results from the Cox regression models estimating risk for 
subsequent autoimmune disease following exposure to an eating disorder in males and females. 
After correcting for multiple testing, we did not observe an increased risk for autoimmune 
diseases after eating disorder exposure in men. However, females with AN (42%), other eating 
disorders (58%), any eating disorder (53%), or BN (48%) were at increased risk for later 
autoimmune diseases. 
We evaluated the risk for celiac disease, Crohn's disease, ulcerative colitis, psoriasis, 
arthritis, lupus, and type 1 diabetes following a diagnosis of AN, other eating disorders, any 
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eating disorder, or BN in males and females. Males diagnosed with eating disorders did not show 
an increased risk for subsequent autoimmune diseases after correcting for multiple testing. In 
females, prior exposure to AN (83%), other eating disorders (69%), and any eating disorder 
(72%) increased risk for celiac disease. Other eating disorders (72%) and any eating disorder 
exposure (63%) showed increased risk for Crohn's disease. Exposure to other eating disorders 
increased the risk for subsequent psoriasis by 38%. 
Temporal Proximity of Risk of Autoimmune Disease Following Exposure to an Eating Disorder 
We explored effects of temporal proximity between exposure to eating disorders and risk 
for autoimmune disease in females (eTable 3) as only females had significant findings. Exposure 
to AN was associated with an increased risk (105%) of being diagnosed with any autoimmune 
disease within the first year after AN diagnosis and with a 49% increased risk between years 1 
and 4. Similarly, risk for celiac disease was increased 217% within the first year and 84% in 
years 1 to 4 after AN diagnosis. The exposure to other eating disorders increased the risk of 
being diagnosed with any autoimmune disease for all three time periods: 216% for 1 year after 
diagnosis; 47% for 1 to 4 years between diagnoses; and 45% for >4 years. Other eating disorders 
increased the risk of being diagnosed with celiac disease (165%) and Crohn’s disease (188%) 
within the first year. The increased risk for celiac disease persisted between 1 year and 4 years at 
55%. Within the first year, females with any eating disorder were at 114% increased risk of 
developing any autoimmune disease; 48% increased risk between years 1 and 4; and 32% 
increased risk >4 years. Any eating disorder increased the risk for celiac disease and Crohn's 
disease within the first year after diagnoses by 189% and 202%, respectively. The risk of being 
diagnosed with celiac disease persisted between years 1 and 4 at 58%. BN was associated with a 
79% increased risk for any autoimmune disease after 4 years of BN diagnosis.  
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Discussion 
With 2.5 million participants and over 26,000 individuals diagnosed with an eating 
disorder, to our knowledge, this is the largest prospective register-based study examining the 
bidirectional associations between autoimmune diseases and eating disorders. Consistent with 
previous research, we observed positive and strong associations between eating disorders and 
autoimmune diseases that are on par with reported associations in epidemiological investigations 
between autoimmune diseases and other psychiatric disorders, such as attention-
deficit/hyperactivity disorder (Nielsen, Benros, & Dalsgaard, 2017), depression (Andersson et 
al., 2015; Euesden, Danese, Lewis, & Maughan, 2017), and schizophrenia (Benros et al., 2014; 
Chen et al., 2012). We extended previous observations by investigating a variety of autoimmune 
diseases previously associated with eating disorders in case reports, clinical samples, and smaller 
cohort studies (Wotton et al., 2016). Our results replicate bidirectional risk patterns of eating 
disorders and autoimmune diseases explored in two clinical cohort studies (Raevuori et al., 2014; 
Wotton et al., 2016) and a Danish national study (Zerwas et al., 2017).  
In men, we did not observe any bidirectional patterns. Preceding autoimmune arthritis 
and type 1 diabetes increased the risk for other eating disorders and preceding autoimmune 
arthritis increased the risk for any eating disorder. The UK study also observed a significantly 
increased risk for BN in males with type 1 diabetes based on reports from five cases (Wotton et 
al., 2016).  
In women, AN showed a bidirectional relationship with celiac disease, replicating 
reported results (Mårild et al., 2017; Wotton et al., 2016). Crohn’s disease increased risk for AN 
(Raevuori et al., 2014; Wotton et al., 2016), but was not bidirectionally associated (Wotton et al., 
2016). The gastrointestinal-related autoimmune diseases celiac and Crohn's showed a 
bidirectional relationship with other eating disorders. The Finnish study (Raevuori et al., 2014) 
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showed increased odds for Crohn’s disease and BN, whereas the UK study (Wotton et al., 2016) 
found an increased risk for celiac disease after BN. Ulcerative colitis increased risk for other 
eating disorders. Additionally, psoriasis showed a bidirectional relationship with other eating 
disorders, replicating findings from the UK study (Wotton et al., 2016) and clinical case reports 
(Basavaraj, Navya, & Rashmi, 2011; Crosta et al., 2014; Ferreira, Abreu, Reis, & Figueiredo, 
2016). Type 1 diabetes increased risk for AN, other eating disorders, and BN as previously 
reported (Raevuori et al., 2014; Wotton et al., 2016); however, Wotton et al. (2016) reported an 
increased risk for type 1 diabetes after AN and BN which we did not replicate.  
The bidirectional nature of some associations suggests either a shared underlying 
mechanism or a third explanatory variable that influences risk for both disease groups. Such risk-
elevating factors could be genetic, environmental, or a combination of both. Current evidence 
suggests that dysregulated immune function may be one shared underlying mechanism. Several 
biological factors influencing immune function are described to be predominant or altered in 
eating disorders: a female preponderance (Chowen, Argente-Arizón, Freire-Regatillo, & 
Argente, 2017; Klein & Flanagan, 2016; McCarthy, Nugent, & Lenz, 2017), metabolic changes 
mediated by adipokines such as leptin and adiponectin (Abella et al., 2017; de Candia et al., 
2017; Nikolajczyk, Jagannathan-Bogdan, Shin, & Gyurko, 2011; Saucillo, Gerriets, Sheng, 
Rathmell, & Maciver, 2014), elevated cytokines (Solmi et al., 2015), abnormal levels of estrogen 
(Khan & Ansar Ahmed, 2015; Klump, Culbert, & Sisk, 2017), and lower abundance or diversity 
of intestinal microbiota (Carr, Kleiman, Bulik, Bulik-Sullivan, & Carroll, 2016; Kleiman et al., 
2015; Lam, Maguire, Palacios, & Caterson, 2017; Postler & Ghosh, 2017; Rooks & Garrett, 
2016). These factors potentially influence the relationship between eating disorders and 
autoimmunity. For example, cortisol levels are dysregulated in eating disorders (Monteleone et 
al., 1999) possibly due to an altered stress response. Cortisol is often included in the therapeutic 
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regimen for autoimmune diseases (Ilzarbe et al., 2017; Straub & Cutolo, 2016). Furthermore, 
Fetissov et al. detected autoantibodies against appetite-regulating peptides, including α-
Melanocyte-stimulating hormone and adrenocorticotropic hormone in AN and BN (Fetissov et 
al., 2002, 2005, 2008). However, the role of autoantibodies in autoimmune diseases is not fully 
understood. Antibodies may be an epiphenomenon or have a causal effect facilitating aberrant 
immune cell function leading to cytotoxicity.  
Recent research suggests a genetic overlap between several autoimmune diseases and 
psychiatric disorders; however, the only study to date that has included eating disorders revealed 
no significant genetic associations between AN and autoimmune diseases or traits (Tylee et al., 
2017). The increased risk for eating disorders after type 1 diabetes could be metabolically 
mediated through a dysregulation of insulin homeostasis, administration of mandatory external 
insulin, and insulin misuse (Bryden et al., 1999; Colton et al., 2015; Colton, Olmsted, Daneman, 
Rydall, & Rodin, 2004). Similarly, increased risk of any eating disorder after ulcerative colitis 
could be due to symptom- and therapy-related behavioral changes as treatment often includes 
dietary changes and a colectomy with pouches or stoma (Ungaro, Mehandru, Allen, Peyrin-
Biroulet, & Colombel, 2017). Patients suffering from inflammatory bowel disease often report 
eating behavior changes related to their disease, and many perceive food as a risk factor for 
relapse decreasing their pleasure in eating (Zallot et al., 2013). Moreover, the increased risk of 
being diagnosed with a gastrointestinal-related autoimmune disease within the first year of 
having been diagnosed with an eating disorder may suggest diagnostic uncertainty due to the 
overlap in their clinical presentation complicating the differential diagnosis (Golden & Park, 
2017; Ilzarbe et al., 2017; Tokatly Latzer et al., 2018). 
Environmental factors, such as diet, dietary behavior, and smoking, also influence the 
human immune system. Starvation and food restriction (as seen in AN) could reduce 
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inflammation and attenuate symptoms in autoimmune illnesses (Hafström, Ringertz, 
Gyllenhammar, Palmblad, & Harms-Ringdahl, 1988). For gastrointestinal-associated immune 
diseases, dietary changes are often prescribed to control pain, diarrhea, and bleeding (Lane, 
Zisman, & Suskind, 2017). All of these processes may be active, and the inclusion of genetic, 
biological, and environmental confounders, as well as a developmental perspective in 
prospective studies are needed to further clarify the relationships between eating disorders and 
autoimmune diseases. 
 
Strengths and Limitations 
Study strengths include the total-population design and substantially more eating disorder 
cases than in previous studies (Mårild et al., 2017; Raevuori et al., 2014; Wotton et al., 2016; 
Zerwas et al., 2017). Prospectively collected data allowed us to explore bidirectional risk and 
minimized the risk of recall bias since data were routinely collected blind to the hypothesis of 
this study. For most chronic diseases in the inpatient register, the positive predictive value was 
found to differ between diagnoses in the NPR and medical journals, but is generally 85-95% 
(Ludvigsson et al., 2011). In addition, we investigated specific autoimmune diseases, which can 
inform disease detection, treatment, and management. 
The observed bidirectional relationships contribute to evidence of immune system 
involvement in some subtypes of eating disorders. However, we cannot entirely rule out 
misdiagnosis or surveillance bias given symptom overlap, especially with gastrointestinal 
autoimmune diseases. Despite the large sample size and follow-up period, some autoimmune 
disease risk periods remain outside study timeline (e.g., rheumatoid arthritis age of onset is 
typically after age 44; Symmons, 2002) and exact ages of onset for diseases cannot be traced in 
register data. Moreover, although the study covers the peak age of onset for eating disorders 
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(Javaras et al., 2015), individuals remain at risk across the lifespan. A longer follow-up period 
could alter some of the bidirectional relationships. Additionally, we were unable to evaluate the 
associations of BED because it could not be distinguished from other eating disorders in the 
NPR. The small number of male eating disorder cases limited our investigation of sex 
differences. Given the large sample size, small differences in prevalence between the sexes 
would be statistically significant, but their clinical significance questionable. Furthermore, the 
assumptions of proportional hazards were violated in some of the associations (Tables 2-3). 
Lastly, the Swedish versions of ICD-8 and ICD-9 could not distinguish between type 1 diabetes 
and type 2 diabetes; however, as our cohort is young (≤34 years), most individuals with ICD-8 or 
ICD-9 diabetes are assumed to have type 1 diabetes. Diabetes diagnoses according to ICD-10, 
the largest proportion in our cohort, are classified into type 1 or type 2. 
 
 
Conclusions 
Results clarify the bidirectional relation between eating disorders and autoimmune 
processes. Clinically, our results encourage vigilance for the emergence of these illnesses in 
afflicted individuals. As the size of genomic investigations of both eating disorders and 
autoimmune diseases increases, we will be well positioned to further explore the extent to which 
shared genetic factors influence risk for both classes of illness. Identifying common 
environmental risk factors although less tractable, may also be facilitated by the identification of 
risk variants or profiles. 
 
  
Key Points 
● In the largest prospective register-based study to date on eating disorders and 
autoimmune diseases, we replicated strong bidirectional relationships between eating 
disorders and various autoimmune diseases. 
● The observed positive and strong associations between eating disorders and 
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